PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:05 AM ET

Sponsor Check › Person

JR
No photo found yet (own website and image search run after this page is viewed)

John M. Reher

Named as an officer, director or promoter on SEC Form D filings · CA, DC · Dec 2, 2009 → Sep 29, 2017

4deals (issuers)
$44.5Mreported sold
81investors
18Form D filings
2009–2017years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

John M. Reher is listed as an executive officer and director on 18 SEC Form D filings by 4 issuers between Dec 2009 and Aug 2018: BrainScope Company, Inc. (Bethesda, MD — other health care — 2009–2017; $16.5M reported sold to 43 investors), Brain Trust Accelerator Fund II, L.P. (Burlingame, CA — pooled investment fund — 2016–2017; $12M reported sold to 21 investors), Chase Pharmaceuticals Corp (Washington, DC — pharmaceuticals — 2011–2016; $12M reported sold to 14 investors) and Chase Therapeutics Corp (Washington, DC — pharmaceuticals — 2018; $4M reported sold to 3 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $44.5M sold in total.

Listed alongside Gail Wilensky (8 shared filings), James Peake (8 shared filings), Karoly Nikolich (8 shared filings), Miles Gilburne (8 shared filings), Thomas N. Chase (8 shared filings) and 20 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.

3 of the issuers belong to the sponsor group Chase (3 issuers, $28M reported sold, 2011–2018).

What this means A sponsor group is one team that sets up a new company for each deal. Chase has 3 companies on file and $28M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.

What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 18 public filings for John M. Reher and found 17 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for John M. Reher has not run yet — it is joining a line of 6,288 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 1 closed (disposition not in docket feed), 1 dismissed

Reher v. State Farm Fire and Casualty Company closed
District Court, M.D. Louisiana · No. 3:22-cv-00695 · Filed Oct 1, 2022 · Closed Jun 12, 2023
Role of Reher: Plaintiff · Outcome: Terminated 2023-06-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 6 federal dockets); surname only in the caption; court in LA (not a filing state)
Reher v. Savage Transportation Management Inc dismissed
District Court, D. Wyoming · No. 2:08-cv-00077 · Filed Mar 25, 2008 · Closed Feb 1, 2011 · Nature of suit: 330 Federal employers' liability
Role of Reher: Plaintiff · Outcome: Terminated 2011-02-01 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 6 federal dockets); surname only in the caption; court in WY (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched John M. Reher..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

John B. Reher closed
United States Bankruptcy Court, D. New Jersey · No. 06-21349 · Filed Nov 15, 2006 · Closed Jul 24, 2007
Role of John B. Reher: Debtor · Outcome: Case closed 2007-07-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 6 federal dockets); first name matches; court in NJ (not a filing state); middle initial differs
John William Reher closed
United States Bankruptcy Court, D. Kansas · No. 98-41209 · Filed May 7, 1998 · Closed Sep 16, 1998
Role of John William Reher: Debtor · Outcome: Case closed 1998-09-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 6 federal dockets); different first name (william); court in KS (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

17 differences found between the filings for John M. Reher — 4 worth asking about (compared 18 filings on Oct 24, 2026)

Worth asking · Dec 2, 2009 – Jan 11, 2010

Amount sold went down between filings — BrainScope Company, Inc.

The Dec 2, 2009 filing says $970,000 sold; the Jan 11, 2010 Form D says $385,000 sold — $585,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Dec 2, 2009 ↗Form D (later) · Jan 11, 2010 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 30, 2009 – Dec 2, 2009

Amount sold went down between filings — BrainScope Company, Inc.

The Oct 30, 2009 filing says $1,593,750 sold; the Dec 2, 2009 Form D says $970,000 sold — $623,750 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Oct 30, 2009 ↗Form D (later) · Dec 2, 2009 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 30, 2009 – Dec 2, 2009

Investor count went down between filings — BrainScope Company, Inc.

The Oct 30, 2009 filing reports 9 investors; the Dec 2, 2009 Form D reports 3 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Oct 30, 2009 ↗Form D (later) · Dec 2, 2009 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Worth asking · Feb 23, 2010 – Sep 29, 2017

7 Form Ds were filed more than 15 days after the first sale

Form D filed 147 days after the first sale — BrainScope Company, Inc. · Form D filed 68 days after the first sale — Chase Pharmaceuticals Corp · Form D filed 105 days after the first sale — BrainScope Company, Inc. · Form D filed 34 days after the first sale — Chase Pharmaceuticals Corp · Form D filed 21 days after the first sale — Chase Pharmaceuticals Corp · and 2 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Sep 29, 2017 ↗BrainScope Company, Inc. — PartnerFacts page ↗Form D · Feb 17, 2016 ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗
Sources
Note · Feb 16, 2016 – Feb 17, 2016

John M. Reher's role changed at Chase Pharmaceuticals Corp: director → executive officer, director

The Feb 16, 2016 filing lists John M. Reher as director; the Feb 17, 2016 Form D/A lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 16, 2016 ↗Form D/A · Feb 17, 2016 ↗John M. Reher — PartnerFacts page ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗
Sources
Note · Feb 17, 2016

John M. Reher's role changed at Chase Pharmaceuticals Corp: executive officer, director → director

The Feb 17, 2016 filing lists John M. Reher as executive officer, director; the Feb 17, 2016 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Feb 17, 2016 ↗Form D · Feb 17, 2016 ↗John M. Reher — PartnerFacts page ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗
Sources
Note · Oct 30, 2009 – Feb 17, 2016

6 offerings changed their target amount between filings

Offering amount changed between filings — Chase Pharmaceuticals Corp · Offering amount changed between filings — BrainScope Company, Inc. · Offering amount changed between filings — BrainScope Company, Inc. · Offering amount changed between filings — BrainScope Company, Inc. · Offering amount lowered between filings — BrainScope Company, Inc. · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Aug 20, 2015 ↗Form D/A (later) · Feb 17, 2016 ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗Form D/A (earlier) · Nov 15, 2011 ↗
Sources
Note · Jun 18, 2009 – Apr 4, 2017

6 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Brain Trust Accelerator Fund II, L.P. (latest filing Apr 4, 2017) · No amendment in the last 12 months on an offering that may still be open — Chase Pharmaceuticals Corp (latest filing Feb 17, 2016) · No amendment in the last 12 months on an offering that may still be open — Chase Pharmaceuticals Corp (latest filing Feb 16, 2016) · No amendment in the last 12 months on an offering that may still be open — BrainScope Company, Inc. (latest filing Sep 3, 2015) · No amendment in the last 12 months on an offering that may still be open — Chase Pharmaceuticals Corp (latest filing May 30, 2014) · and 1 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Apr 4, 2017 ↗Brain Trust Accelerator Fund II, L.P. — PartnerFacts page ↗Form D · Feb 17, 2016 ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗
Sources
Note · Dec 2, 2009 – Aug 28, 2018

John M. Reher is written 2 different ways on the filings

listed as "John M. Reher" on 17 filings (from Dec 2, 2009), and "John Reher" on the Aug 28, 2018 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Dec 2, 2009 ↗Form D · Aug 28, 2018 ↗John M. Reher — PartnerFacts page ↗
Sources
Note · Jul 6, 2009 – Oct 30, 2009

Industry group changed between filings — BrainScope Company, Inc.

"Biotechnology" (Jul 6, 2009); then "Other Health Care" (Oct 30, 2009 to Sep 29, 2017).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jul 6, 2009 ↗Form D · Oct 30, 2009 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Note · Sep 3, 2015 – Sep 29, 2017

Address moved from Washington, DC to Bethesda, MD — BrainScope Company, Inc.

The people listed on the Sep 3, 2015 filing give Washington, DC; on the Sep 29, 2017 filing they give Bethesda, MD.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Sep 3, 2015 ↗Form D · Sep 29, 2017 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Note · Feb 17, 2016 – Mar 28, 2016

Address moved from Washington, Dc, DC to Washington, DC — Chase Pharmaceuticals Corp

The people listed on the Feb 17, 2016 filing give Washington, Dc, DC; on the Mar 28, 2016 filing they give Washington, DC.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D/A · Feb 17, 2016 ↗Form D · Mar 28, 2016 ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗
Sources
Note · Aug 20, 2015 – Feb 16, 2016

Address moved from Washington, DC to Washington, Dc, DC — Chase Pharmaceuticals Corp

The people listed on the Aug 20, 2015 filing give Washington, DC; on the Feb 16, 2016 filing they give Washington, Dc, DC.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Aug 20, 2015 ↗Form D · Feb 16, 2016 ↗Chase Pharmaceuticals Corp — PartnerFacts page ↗
Sources
Note · Dec 2, 2009 – Aug 28, 2018

John M. Reher is listed with 2 different address states: CA, DC

CA on 11 filings (Dec 2, 2009 to Sep 29, 2017); DC on 7 filings (May 30, 2014 to Aug 28, 2018).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Dec 2, 2009 ↗Form D · May 30, 2014 ↗
Sources
Note · Jan 11, 2010 – Mar 16, 2010

Minimum investment changed between filings — BrainScope Company, Inc.

The Jan 11, 2010 filing lists a minimum of $60,000; the Mar 16, 2010 Form D lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jan 11, 2010 ↗Form D (later) · Mar 16, 2010 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Note · Dec 2, 2009 – Jan 11, 2010

Minimum investment changed between filings — BrainScope Company, Inc.

The Dec 2, 2009 filing lists a minimum of $70,000; the Jan 11, 2010 Form D lists $60,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Dec 2, 2009 ↗Form D (later) · Jan 11, 2010 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
Note · Oct 30, 2009 – Dec 2, 2009

Minimum investment changed between filings — BrainScope Company, Inc.

The Oct 30, 2009 filing lists a minimum of $750; the Dec 2, 2009 Form D lists $70,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Oct 30, 2009 ↗Form D (later) · Dec 2, 2009 ↗BrainScope Company, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 12 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 28, 2018 D
Chase Therapeutics Corp
File 021-320230
$0$0$0None listed on this filingEDGAR ↗
Sep 29, 2017 D
BrainScope Company, Inc.
File 021-295689
$0$0$0None listed on this filingEDGAR ↗
Apr 4, 2017 D/A
Brain Trust Accelerator Fund II, L.P.
File 021-260033
$0$0$0None listed on this filingEDGAR ↗
Mar 28, 2016 D
Chase Pharmaceuticals Corp
File 021-260084
$0$0$0None listed on this filingEDGAR ↗
Feb 17, 2016 D/A
Chase Pharmaceuticals Corp
File 021-246193
$0$0$0None listed on this filingEDGAR ↗
Feb 17, 2016 D
Chase Pharmaceuticals Corp
File 021-257591
$0$0$0None listed on this filingEDGAR ↗
Feb 16, 2016 D
Chase Pharmaceuticals Corp
File 021-257589
$0$0$0None listed on this filingEDGAR ↗
Sep 3, 2015 D/A
BrainScope Company, Inc.
File 021-152524
$0$0$0None listed on this filingEDGAR ↗
Sep 3, 2015 D
BrainScope Company, Inc.
File 021-247013
$0$0$0None listed on this filingEDGAR ↗
May 30, 2014 D
Chase Pharmaceuticals Corp
File 021-218283
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 5, 2011 D
Chase Pharmaceuticals Corp
File 021-153008
$0$0$0None listed on this filingEDGAR ↗
Mar 16, 2010 D
BrainScope Company, Inc.
File 021-92051
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named John M. Reher on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CT
Pharmaceuticals · group: Chase

Chase Therapeutics Corp

Washington, DC · Aug 28, 2018
  • Aug 28, 2018 · D · $4,000,000 sold of $4,000,000 · 3 investors · min. $1 · role: Director EDGAR ↗

Raised $4M from 3 investors (100% of the $4M target) as of the latest filing. John is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BC
Other Health Care

BrainScope Company, Inc.

Bethesda, MD · Dec 2, 2009 → Sep 29, 2017 · 8 filings
  • Sep 29, 2017 · D · $16,386,250 sold of $16,386,250 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 3, 2015 · D · $2,465,000 sold of $2,915,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 3, 2015 · D/A · $16,500,000 sold of $16,500,000 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 15, 2011 · D/A · $5,575,000 sold of $6,500,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 27, 2010 · D · $1,600,000 sold of $3,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 16, 2010 · D · $2,400,000 sold of $4,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 11, 2010 · D · $385,000 sold of $385,000 · 3 investors · min. $60,000 · role: Director EDGAR ↗
  • Dec 2, 2009 · D · $970,000 sold of $1,199,421 · 3 investors · min. $70,000 · role: Director EDGAR ↗

Raised $16.5M from 43 investors (100% of the $16.4M target) as of the latest filing. John is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BT
Pooled Investment Fund · group: Chase

Brain Trust Accelerator Fund II, L.P.

Burlingame, CA · Mar 25, 2016 → Apr 4, 2017 · 2 filings
  • Apr 4, 2017 · D/A · $12,030,500 sold of $20,000,000 · 21 investors · min. No minimum reported · role: Executive Officer, Director (Managing Member of the General Partner of the Issuer) EDGAR ↗
  • Mar 25, 2016 · D · $7,230,000 sold of $20,000,000 · 19 investors · min. No minimum reported · role: Executive Officer, Director (Member of General Partner of the Issuer) EDGAR ↗

Raised $12M from 21 investors (60% of the $20M target) as of the latest filing. John is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pharmaceuticals · group: Chase

Chase Pharmaceuticals Corp

Washington, DC · Jan 5, 2011 → Mar 28, 2016 · 7 filings
  • Mar 28, 2016 · D · $11,974,004 sold of $11,974,004 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 17, 2016 · D · $0 sold of $106,650 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 17, 2016 · D/A · $3,500,000 sold of $3,500,000 · 13 investors · min. No minimum reported · role: Director, Executive Officer EDGAR ↗
  • Feb 16, 2016 · D · $0 sold of $612,500 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 20, 2015 · D · $3,000,000 sold of $3,000,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 30, 2014 · D · $6,137,999 sold of $8,586,000 · 6 investors · min. $1 · role: Director EDGAR ↗
  • Jan 5, 2011 · D · $1,200,000 sold of $1,200,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $12M from 14 investors (100% of the $12M target) as of the latest filing. John is listed as director, executive officer on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around John 25

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

BT
Management entity

Brain Trust Management II, L.L.C.

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Miles Gilburne

Director · 8 shared filings (1 issuer) · also on 6 other issuers

Miles Gilburne is on 7 issuers in total — a repeat sponsor. Their page lists every one.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

James Peake

Director · 8 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

GW
No photo found yet (own website and image search run after this page is viewed)
Person

Gail Wilensky

Director · 8 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

TC
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas N. Chase

Executive Officer, Director · 8 shared filings (2 issuers)

Listed on the same filings as John M. Reher. Their page shows their other deals.

KN
No photo found yet (own website and image search run after this page is viewed)
Person

Karoly Nikolich

Director · 8 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as John M. Reher. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kathleen Clarence-Smith

Executive Officer, Director · 7 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as John M. Reher. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jean Case

Director · 7 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as John M. Reher. Their page shows their other deals.

RW
No photo found yet (own website and image search run after this page is viewed)
Person

Raphael Wisniewski

Director · 6 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

VS
No photo found yet (own website and image search run after this page is viewed)
Person

Vikram Sudarsan

Director · 6 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

MA
No photo found yet (own website and image search run after this page is viewed)
Person

Moshe Alafi

Director · 5 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael E. Singer

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John M. Reher. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Cunningham

Director · 5 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

NP
No photo found yet (own website and image search run after this page is viewed)
Person

Nayan Greg Parekh

Director · 4 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Laurie Silver

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Barrett Moore

Director · 3 shared filings (1 issuer) · also on 8 other issuers

Daniel Barrett Moore is on 9 issuers in total — a repeat sponsor. Their page lists every one.

DI
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Ingram

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Singer

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John M. Reher. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Richard P. Dulik

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as John M. Reher. Their page shows their other deals.

GP
No photo found yet (own website and image search run after this page is viewed)
Person

Greg N. Parekh

Director · 2 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

John M. Siebert

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kerstin Schultz

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

CR
No photo found yet (own website and image search run after this page is viewed)
Person

Cynthia Ringo

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Cynthia Ringo is on 6 issuers in total — a repeat sponsor. Their page lists every one.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Case

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as John M. Reher. Their page shows their other deals.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Holman

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as John M. Reher. Their page shows their other deals.

The team behind the deals

C
Sponsor group

Chase

3 issuers · 11 filings · $28M reported sold · 2011–2018

One team, 3 deal companies. John M. Reher is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name John M. Reher.

Same business address

8 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to John M. Reher by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers John M. Reher is listed on: none on file. No website or social profile named in Brain Trust Accelerator Fund II, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #274,332 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Burlingame, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗District of Columbia state courts — find the court ↗Maryland Judiciary case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Maryland Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when John M. Reher appears on a new Form D, or when a court case or SEC action is matched to them. See plans →